Bonesupport is developing a range of innovative products that address various spine conditions from disc hernia to fragility fractures caused by osteoporosis.

Amongst others, it is pioneering the use of an injectable bone cement for vertebral augmentation procedures and a minimally-invasive treatment of low back pain conditions such as disc hernia.

Bonesupport listed on the Nasdaq Stockholm stock exchange in June 2017.

Headquarters
Lund, Sweden

INVESTMENT DATE
November 2006

INVESTMENT THESIS
Venture-stage investment in medical technology

STATUS
Current

INDUSTRY
Orthopedic

STAGE CAPITAL TEAM
Aris Constantinides